- •Vitamin D levels are not predictors of survival in Korean ALS patients.
- •To elucidate the role of vitamin D on ALS, its free-form needs to be measured.
- •Bone mineral density is a better marker for bone health in Korean ALS patients.
- •Older age at onset and bulbar onset are consistently poor prognostic factors.
This study aimed to measure serum 25-hydroxyvitamin D [25(OH)D] concentrations, bone mineral density (BMD), and the parameters of bone metabolism in amyotrophic lateral sclerosis (ALS) patients, and their correlation with survival.
We retrospectively analysed data of 100 ALS patients who consecutively visited a single referral ALS clinic between January and December 2011. Sex; age and site of symptom onset; and death were recorded. Serum 25(OH)D concentration was dichotomized as <10 ng/ml and ≥10 ng/ml.
There was absent relationship between serum 25(OH)D and concentration of bone turnover parameters or between 25(OH)D and BMD. According to the results of the Kaplan–Meier analysis with log-rank test, the survival rates of patients without (≥10 ng/ml) and of those with severe vitamin D deficiency (< 10ng/ml) were not significantly different. Cox regression analysis showed that a poor prognosis was most correlated with older age at onset and bulbar onset after adjustment for all the clinical factors.
In conclusion, vitamin D levels were not correlated to other bone markers and survival in a clinic population of ALS patients.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Prognostic factors in ALS: a critical review.Amyotroph. Lateral Scler. 2009; 10: 310-323
- Survival of patients with amyotrophic lateral sclerosis in a population-based registry.Neuroepidemiology. 2005; 25: 114-119
- The ALSFRSr predicts survival time in an ALS clinic population.Neurology. 2005; 64: 38-43
- Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis.J. Neurol. Neurosurg. Psychiatry. 2010; 81: 1249-1252
- Physical activity and the association with sporadic ALS.Neurology. 2005; 64: 241-245
- Lifetime physical activity and the risk of amyotrophic lateral sclerosis.J. Neurol. Neurosurg. Psychiatry. 2013; 84: 976-981
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.Neurology. 2008; 70: 1004-1009
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis.Muscle Nerve. 2011; 44: 20-24
- Prior medical conditions and the risk of amyotrophic lateral sclerosis.J. Neurol. 2014; 261: 1949-1956
- Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study.JAMA Neurol. 2015; 72: 40-48
- Vitamin D and bone health.J. Nutr. 1996; 126: 1159S-1164S
- The effect of vitamin D on bone and osteoporosis.Best Pract. Res. Clin. Endocrinol. Metab. 2011; 25: 585-591
- Vitamin D as a potential therapy in amyotrophic lateral sclerosis.CNS Neurosci. Ther. 2014; 20: 101-111
- Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis.J. Clin. Neurosci. 2013; 20: 1550-1553
- Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis.Neurobiol. Aging. 2014; 35: 1198-1205
- Vitamin D is not a protective factor in ALS.CNS Neurosci. Ther. 2015; 21: 651-656
- Vitamin D(3) at 50× AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.PLoS ONE. 2013; 8e30243
- Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis.PLoS ONE. 2011; 6e29354
- Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.CNS Neurosci. Ther. 2012; 18: 547-557
- El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000; 1: 293-299
- Prevention and Management of Osteoporosis: Report of a WHO Scientific Group.2003 (2003. Report No)
- Vitamin D deficiency.N. Engl. J. Med. 2007; 357: 266-281
- Optimal serum concentration of 25-hydroxyvitamin D for bone health in older Korean adults.Calcif. Tissue Int. 2013; 92: 68-74
- Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis.Eur. Neurol. 1997; 37: 225-229
- Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain.J. Chem. Neuroanat. 2005; 29: 21-30
- In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue.Histochem. J. 2001; 33: 19-24
- Vitamin D and DBP: the free hormone hypothesis revisited.J. Steroid Biochem. Mol. Biol. 2014; 144: 132-137
- Prognostic factors in amyotrophic lateral sclerosis: a population-based study.PLoS ONE. 2015; 10e0141500
Published online: May 06, 2016
Accepted: May 5, 2016
Received in revised form: April 28, 2016
Received: March 10, 2016
© 2016 Elsevier B.V. All rights reserved.